Executive Summary: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
- PMID: 27521441
- PMCID: PMC4981763
- DOI: 10.1093/cid/ciw504
Executive Summary: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
Erratum in
-
Erratum.Clin Infect Dis. 2017 May 1;64(9):1298. doi: 10.1093/cid/ciw798. Clin Infect Dis. 2017. PMID: 28168308 Free PMC article. No abstract available.
-
Erratum.Clin Infect Dis. 2017 Oct 1;65(7):1251. doi: 10.1093/cid/cix586. Clin Infect Dis. 2017. PMID: 30060023 Free PMC article. No abstract available.
Abstract
It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. IDSA considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances.These guidelines are intended for use by healthcare professionals who care for patients at risk for hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), including specialists in infectious diseases, pulmonary diseases, critical care, and surgeons, anesthesiologists, hospitalists, and any clinicians and healthcare providers caring for hospitalized patients with nosocomial pneumonia. The panel's recommendations for the diagnosis and treatment of HAP and VAP are based upon evidence derived from topic-specific systematic literature reviews.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.
Comment in
-
Management of Adults with Hospital-acquired and Ventilator-associated Pneumonia.Ann Am Thorac Soc. 2016 Dec;13(12):2258-2260. doi: 10.1513/AnnalsATS.201608-641CME. Ann Am Thorac Soc. 2016. PMID: 27925784 No abstract available.
References
-
- American Thoracic Society (ATS) and Infectious Diseases Society of America (IDSA). Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388–416. - PubMed
-
- US Food and Drug Administration (FDA). Information for healthcare professionals: colistimethate (marketed as Coly-Mycin M and generic products). Available at: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPa.... Accessed September 2014.
-
- Nation RL, Li J, Cars O et al. . Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus. Lancet Infect Dis 2015; 15:225–34. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical